Evidence map›Paper›PMID 25360784›Full record

ArticlePloS one2014

Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination.

Ricardo Q Gurgel, Alberto De Juan Alvarez, Alda Rodrigues, Robergson R Ribeiro, Sílvio S Dolabella, Natanael L Da Mota, Victor S Santos, Miren Iturriza-Gomara, Nigel A Cunliffe, Luis E Cuevas

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ricardo Q GurgelFederal University of Sergipe, Aracaju, Brazil.
Alberto De Juan AlvarezLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Alda RodriguesFederal University of Sergipe, Aracaju, Brazil.
Robergson R RibeiroFederal University of Sergipe, Aracaju, Brazil.
Sílvio S DolabellaFederal University of Sergipe, Aracaju, Brazil.
Natanael L Da MotaFederal University of Sergipe, Aracaju, Brazil.
Victor S SantosFederal University of Sergipe, Aracaju, Brazil.
Miren Iturriza-GomaraInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Nigel A CunliffeInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Luis E CuevasLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Universidade Federal de Sergipe · BRLiverpool School of Tropical Medicine · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsRotavirus causes severe diarrhoea and Brazil introduced the Rotarix G1P[8] vaccine in 2006. We aimed to describe changes in rotavirus incidence and diarrhoea epidemiology before and after vaccine introduction.

methods

design(i) hospital-based survey of children with diarrhoea (2006-2012); (ii) diarrhea-mortality and hospitalization surveillance (1999-2012).

setting(i) Aracaju and (ii) state and national level.

results1841 children were enrolled and 231 (12.5%) had rotavirus. Rotavirus was less frequent from January-June than from July-December (9.4% versus 20.9%, p<0.01), but the seasonal variation was less defined after 2009. Very few rotavirus cases (8-3.9%) were detected in 2011, with an increase in 2012 (13-18.5%). In 2006, unvaccinated children were more likely to have rotavirus, but thereafter unvaccinated and vaccinated children had equally low incidence. Older children and those with rotavirus were more likely to have severe diarrhea episodes. The most frequent genotype from 2006 to 2010 was G2P[4]; except in 2009, when most cases were G1P[8]. Very few G2P[4] were detected from 2011 and 50% cases in 2012 were G8P[4]. Diarrhoea-hospitalizations decreased nationally from 89,934 (2003) to 53,705 (2012; 40.3% reduction) and in the state from 1729 to 748 (56.7% reduction). Diarrhoea-deaths decreased nationally from 4368 in 1999 to 697 in 2012 (84% reduction, p<0.001) and in the state from 132 to 18 (86% reduction). These changes were much larger after vaccine introduction.

conclusionsThe vaccine was associated with substantial reductions in rotavirus incidence and diarrhoea-hospitalizations and deaths. The G2P[4] genotype predominance disappeared over time and may be replaced by other heterotypic genotypes.

Indexed as

GenotypeVaccinationBrazilChildChild, PreschoolEpidemiological MonitoringFemaleHumansIncidenceInfantInfant, NewbornMaleRotavirus

Identifiers

PMID25360784
PMCPMC4215980
OpenAlexW2036677776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.